Prevalence and predictors of cannabis use among men receiving androgen-deprivation therapy for advanced prostate cancer.
Read MoreADT and the Risk of Cardiovascular Disease and Stroke—a Summary of Two Reviews
Androgen Deprivation Therapy and the Risk of Stroke in Patients with Prostate Cancer: An Updated Systematic Review and Meta-Analysis.
Is Androgen Deprivation Therapy for Prostate Cancer Associated with Cardiovascular disease? A Meta-Analysis and systematic review.
Read MoreDo some ADT medications carry greater risk of cardiovascular disease than others?
The risk of cardiovascular disease in prostate cancer patients receiving androgen deprivation therapies.
Read MoreWhat effect does ADT have on PSMA expression by prostate cancer cells?
Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients.
Read MoreDoes adding just six months of ADT to salvage radiotherapy significantly slow disease progression?
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Read MoreDoes it help to start a supervised exercise program BEFORE starting ADT?
Exercise-induced attenuation of treatment side-effects in newly diagnosed prostate cancer patients beginning androgen deprivation therapy: a randomised controlled trial.
Read MoreFor men on ADT who take a drug holiday, what should be the signal to start back on ADT?
New protocol of intermittent androgen deprivation therapy for patients with metastatic prostate cancer: A retrospective study.
Read MoreWhat can you do to manage hot flashes?
Management of hot flashes in men with prostate cancer.
Read MoreDo Zytiga and Xtandi increase the risk of death from cardiovascular disease for men with pre-existing cardiovascular conditions?
Mortality and hospitalization risk following oral androgen signaling inhibitors among men with advanced prostate cancer by pre-existing cardiovascular comorbidities.
Read MoreDo men on ADT have an increased risk of rheumatoid arthritis?
Androgen Deprivation Therapy for Prostate Cancer and the Risk of Rheumatoid Arthritis: A Population-Based Cohort Study.
Read More